Chemoinformaics analysis of Diferuloyl-Spermidine
| Molecular Weight | 643.737 | nRot | 17 |
| Heavy Atom Molecular Weight | 602.409 | nRig | 24 |
| Exact Molecular Weight | 643.289 | nRing | 3 |
| Solubility: LogS | -3.822 | nHRing | 0 |
| Solubility: LogP | 2.881 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 2 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 88 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 47 | No. of Aromatic Carbocycles | 3 |
| nHetero | 11 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 41 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 36 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 3 | No. of Arom Atom | 18 |
| No. of Oxygen atom | 8 | No. of Arom Bond | 18 |
| nHA | 10 | APOL | 97.1745 |
| nHD | 5 | BPOL | 48.9175 |
| QED | 0.106 |
| Synth | 3.676 |
| Natural Product Likeliness | 0.317 |
| NR-PPAR-gamma | 0.067 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.707 |
| Pgp-sub | 0.927 |
| HIA | 0.943 |
| CACO-2 | -5.936 |
| MDCK | 0.00000884 |
| BBB | 0.008 |
| PPB | 0.951768 |
| VDSS | 1.06 |
| FU | 0.0189329 |
| CYP1A2-inh | 0.084 |
| CYP1A2-sub | 0.618 |
| CYP2c19-inh | 0.068 |
| CYP2c19-sub | 0.064 |
| CYP2c9-inh | 0.113 |
| CYP2c9-sub | 0.776 |
| CYP2d6-inh | 0.055 |
| CYP2d6-sub | 0.889 |
| CYP3a4-inh | 0.538 |
| CYP3a4-sub | 0.738 |
| CL | 9.368 |
| T12 | 0.911 |
| hERG | 0.487 |
| Ames | 0.111 |
| ROA | 0.388 |
| SkinSen | 0.97 |
| Carcinogencity | 0.124 |
| EI | 0.008 |
| Respiratory | 0.713 |
| NR-Aromatase | 0.813 |
| Antiviral | Yes |
| Prediction | 0.965401 |